BMJ Open (May 2024)
What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries
- Partha Basu,
- Martin McKee,
- Adriana Băban,
- Luke Vale,
- Marc Bardou,
- Ana Fernandes,
- Sadie Bell,
- Margarida Teixeira,
- Rebecca Moore,
- Nuno Lunet,
- David Ritchie,
- Romeu Mendes,
- Eric Lucas,
- Paolo Giorgi Rossi,
- Paolo Giorgi Rossi,
- Rosa Legood,
- Berit Andersen,
- Diana Taut,
- Keitly Mensah,
- João Firmino-Machado,
- Mariana Amorim,
- Mette Tranberg,
- Laura Bonvicini,
- Li Sun,
- Anneli Uusküla,
- Pia Kirkegaard,
- Paola Mantellini,
- Ines Baia,
- Lise Rochaix,
- Camilla Fiorina,
- Luca Ghirotto,
- Anna Tisler,
- Wendy Yared,
- Firmino Machado,
- Rikke Buus Bøje,
- Raquel Rico Berrocal,
- Noemi Auzzi,
- Nicoleta Jiboc,
- Kerli Reintamm,
- Raya Michaylova,
- Yulia Panayotova,
- Tatyana Kotzeva,
- Anna Foss,
- Rachel Greenley,
- Letizia Bartolini,
- Giusy Iorio,
- Cláudia Gouvinhas,
- Florian Nicula,
- Alexandra Tolnai,
- Vanessa Moore,
- Isabel Mosquera Metcalfe,
- Violette Delisle,
- Irina Todorova,
- Raya Mihaylova,
- Helena Ros Comesana,
- Meritxel Mallafré-Larrosa,
- Ginevra Papi,
- Arianna Khatchadourian,
- Christiane Dascher-Nade
Affiliations
- Partha Basu
- International Agency for Research on Cancer, Lyon, France
- Martin McKee
- Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK
- Adriana Băban
- Luke Vale
- Newcastle University Population Health Sciences Institute, Newcastle upon Tyne, UK
- Marc Bardou
- CIC-P INSERM 1432, Institut national de la santé et de la recherche médicale, Paris, France
- Ana Fernandes
- Sadie Bell
- Margarida Teixeira
- EPI Unit–Institute of Public Health, University of Porto, Porto, Portugal
- Rebecca Moore
- Nuno Lunet
- EPI Unit–Institute of Public Health, University of Porto, Porto, Portugal
- David Ritchie
- Romeu Mendes
- Eric Lucas
- Paolo Giorgi Rossi
- Epidemiology Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy
- Paolo Giorgi Rossi
- Rosa Legood
- Berit Andersen
- University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark
- Diana Taut
- Babes-Bolyai University, Cluj-Napoca, Romania
- Keitly Mensah
- Early Detection, Prevention and Infections Branch, IARC, Lyon, France
- João Firmino-Machado
- EPI Unit–Institute of Public Health, University of Porto, Porto, Portugal
- Mariana Amorim
- EPI Unit–Institute of Public Health, University of Porto, Porto, Portugal
- Mette Tranberg
- University Research Clinic for Cancer Screening and Department of Public Health Programmes, Randers Regional Hospital, Randers, Denmark
- Laura Bonvicini
- Epidemiology Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy
- Li Sun
- Anneli Uusküla
- University of Tartu, Tartu, Estonia
- Pia Kirkegaard
- University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark
- Paola Mantellini
- Ines Baia
- EPI Unit–Institute of Public Health, University of Porto, Porto, Portugal
- Lise Rochaix
- Camilla Fiorina
- Luca Ghirotto
- Qualitative Research Unit, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy
- Anna Tisler
- Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
- Wendy Yared
- Firmino Machado
- Rikke Buus Bøje
- University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark
- Raquel Rico Berrocal
- Centre d’Etudes des Mouvements Sociaux, Ecole des Hautes Etudes en Sciences Sociales, Paris, France
- Noemi Auzzi
- Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Osservatorio Nazionale Screening, Florence, Italy
- Nicoleta Jiboc
- Babes-Bolyai University, Cluj-Napoca, Romania
- Kerli Reintamm
- Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
- Raya Michaylova
- Health Psychology Research Center, Sofia, Bulgaria
- Yulia Panayotova
- Health Psychology Research Center, Sofia, Bulgaria
- Tatyana Kotzeva
- Health Psychology Research Center, Sofia, Bulgaria
- Anna Foss
- Rachel Greenley
- Letizia Bartolini
- Giusy Iorio
- Cláudia Gouvinhas
- Florian Nicula
- Alexandra Tolnai
- Vanessa Moore
- Isabel Mosquera Metcalfe
- Violette Delisle
- Irina Todorova
- Raya Mihaylova
- Helena Ros Comesana
- Meritxel Mallafré-Larrosa
- Ginevra Papi
- Arianna Khatchadourian
- Christiane Dascher-Nade
- DOI
- https://doi.org/10.1136/bmjopen-2023-079921
- Journal volume & issue
-
Vol. 14,
no. 5
Abstract
Objectives The aim of this study was to map and compare stakeholders’ perceptions of barriers towards cervical cancer screening for vulnerable women in seven European countries.Design In Collaborative User Boards, stakeholders were invited to participate to identify barriers towards participation in cervical cancer screening.Setting The study is nested in the European Union-funded project CBIG-SCREEN which aims to tackle inequity in cervical cancer screening for vulnerable women (www.cbig-screen.eu). Data collection took place in Bulgaria, Denmark, Estonia, France, Italy, Portugal and Romania.Participants Participants represented micro-level stakeholders covering representatives of users, that is, vulnerable women, meso-level stakeholders covering healthcare professionals and social workers, and macro-level stakeholders covering programme managers and decision-makers.Methods Across the seven countries, 25 meetings in Collaborative User Boards with a duration of 2 hours took place between October 2021 and June 2022. The meetings were video recorded or audio recorded, transcribed and translated into English for a qualitative framework analysis.Results 120 participants took part in the Collaborative User Boards. Context-specific barriers were related to different healthcare systems and characteristics of vulnerable populations. In Romania and Bulgaria, the lack of a continuous screening effort and lack of ways to identify eligible women were identified as barriers for all women rather than being specific for women in vulnerable situations. The participants in Denmark, Estonia, France, Italy and Portugal identified providers’ lack of cultural and social sensitivity towards vulnerable women as barriers. In all countries, vulnerable women’s fear, shame and lack of priority to preventive healthcare were identified as psychological barriers.Conclusion The study provides an overview of stakeholders’ perceived barriers towards vulnerable women’s cervical cancer screening participation in seven European countries. The organisation of healthcare systems and the maturity of screening programmes differ between countries, while vulnerable women’s psychological barriers had several similarities.